Brian DeSchuytner
Director of Finance/CFO bij MERSANA THERAPEUTICS, INC.
Vermogen: 244 209 $ op 31-03-2024
Profiel
Brian DeSchuytner is currently the Senior VP, Chief Operating & Financial Officer at Mersana Therapeutics, Inc. He previously worked as the Vice President-ZEJULA Commercial at Tesaro, Inc. from 2017 to 2019, and as the VP-Global Marketing & Head-Global Brand at Millennium Pharmaceuticals, Inc. from 2009 to 2017.
Mr. DeSchuytner completed his undergraduate degree at Dartmouth College and holds an MBA from The Wharton School of the University of Pennsylvania.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
16-01-2024 | 54 511 ( 0.04% ) | 244 209 $ | 31-03-2024 |
Actieve functies van Brian DeSchuytner
Bedrijven | Functie | Begin |
---|---|---|
MERSANA THERAPEUTICS, INC. | Director of Finance/CFO | 10-07-2019 |
Eerdere bekende functies van Brian DeSchuytner
Bedrijven | Functie | Einde |
---|---|---|
TESARO INC | Corporate Officer/Principal | 01-06-2019 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-01-2017 |
Opleiding van Brian DeSchuytner
Dartmouth College | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MERSANA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |